Azacitidine 100mg powder for suspension for injection vials
NHS hospitals in England used £55,056,183 of indicative cost of Azacitidine 100mg powder for suspension for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 6.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Azacitidine 100mg powder for suspension for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Azacitidine 100mg powder for suspension for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| United Lincolnshire Hospitals Nhs Trust | £2,817,642 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,853,454 |
| Western Sussex Hospitals Nhs Found Trust | £1,637,212 |
| Southend Univ Hosp Nhs Foundation Trust | £1,405,017 |
| The Royal Marsden Nhs Foundation Trust | £1,325,088 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,293,550 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,286,247 |
| Norfolk & Norwich University Hpl Nhs Trt | £1,283,358 |
| Nottingham University Hospitals Trust | £1,060,905 |
| Colchester Hospital University Nhs Ft | £1,044,534 |
The primary-care picture
Azacitidine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Azacitidine medicine page.